NASDAQ:IOVA
Iovance Biotherapeutics, Inc. Stock News
$8.88
-0.120 (-1.33%)
At Close: May 31, 2024
Sproutly Announces a Business Transformation Plan and Investment by Infusion Biosciences
12:00am, Friday, 15'th May 2020
Sproutly Canada, Inc. (CSE:SPR) (OTCQB:SRUTF) (FSE:38G) (“Sproutly” or the “Company”) announces a business transformation plan that will shift the Com
Iovance Biotherapeutics Announces Clinical Data Updates for Lifileucel in Advanced Melanoma
09:01pm, Wednesday, 13'th May 2020
Iovance Biotherapeutics, Inc. (IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced new interim data from Cohort 2 in the C-144-01 study of l
Gilead and Kite Continue to Advance Next Generation Cancer Therapies at 2020 American Society of Clinical Oncology Annual Meeting
12:00am, Wednesday, 13'th May 2020
Gilead Sciences, Inc. (Nasdaq: GILD) and Kite, a Gilead Company, today announced the acceptance of nine abstracts, including three oral presentations
Truth Tracker: 'Plandemic' video full of false conspiracy theories about COVID-19
02:45pm, Tuesday, 12'th May 2020
A documentary-style video called 'Plandemic' has been removed by social media platforms after peddling potentially dangerous conspiracy theories about the coronavirus pandemic, including that it was e
Biotech's Golden Moment As Healthcare Attracts Investors
01:31pm, Tuesday, 12'th May 2020
Biotechs are not as broadly and deeply affected by COVID-19 disruption and now lead the market as the economy begins the recovery process. Healthcare has attrac
JPMorgan Genetic-Therapies Fund Finds Success in Covid-19 Era
03:13am, Tuesday, 12'th May 2020
(Bloomberg) -- JPMorgan Asset Management now has more than $400 million in its Thematics - Genetic Therapies fund launched in October, just before the world’s need for such technologies came into fo
Breaks in health insurance hurt cancer care, survival
09:25pm, Monday, 11'th May 2020
Health insurance disruptions are never a good thing, but for people with cancer it can lead to poor care and lower odds of survival, a new study finds.
Intel Works with University of Pennsylvania in Using Privacy-Preserving AI to Identify Brain Tumors
12:00am, Monday, 11'th May 2020
Intel and the Perelman School of Medicine at the University of Pennsylvania are setting up a federation to train AI models that identify brain tumors.